Xencor | XNCR - EPS Earnings Per Share


Xencor reported $-0.09 in EPS Earnings Per Share for its fiscal quarter ending in December of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q1 Mar/2026 -0.66 -0.66 May/13
FY2025Q4 Dec/2025 -0.09 -0.6 -0.62 Feb/25
FY2025Q3 Sep/2025 -0.08 -0.69 -0.71 Nov/05
FY2025Q2 Jun/2025 -0.41 -0.65 -1.07 Aug/06
FY2025Q1 Mar/2025 -0.66 -0.80 -1.11 May/07




Eps Change Date
AbbVie USD 2.65 0.06 Mar/2026
Alnylam Pharmaceuticals USD 1.99 0.74 Mar/2026
Amgen USD 5.15 0.14 Mar/2026
Arrowhead Research USD 0.22 0.33 Dec/2025
AstraZeneca USD 2.58 0.46 Mar/2026
Biogen USD 3.57 1.58 Mar/2026
Bristol-Myers Squibb USD 1.58 0.32 Mar/2026
Cytokinetics USD -1.67 0.17 Mar/2026
GlaxoSmithKline GBP 0.43 0.17 Mar/2026
J&J USD 2.7 0.24 Mar/2026
Karyopharm Therapeutics USD -2.22 2.07 Dec/2025
MacroGenics USD -0.22 0.49 Dec/2025
Merck USD -1.28 3.32 Mar/2026
Novartis USD 1.99 0.04 Mar/2026
Pfizer USD 0.75 0.09 Mar/2026
Regeneron Pharmaceuticals USD 9.47 1.97 Mar/2026
Roche Holding CHF 8.37 2.95 Dec/2025
Xencor USD -0.09 0.01 Dec/2025